Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound

Maria Assunta Zocco, Enrico Di Stasio, Gian Ludovico Rapaccini, Maurizio Pompili, Antonio Gasbarrini, Matteo Garcovich, Andrea Lupascu, Davide Roccarina, Brigida Eleonora Annicchiarico, Laura Riccardi, Maria Elena Ainora, Francesca Romana Ponziani, Gianluigi Caracciolo, Raffaele Landolfi, Massimo Siciliano

Risultato della ricerca: Contributo in rivistaArticolo in rivista

54 Citazioni (Scopus)

Abstract

Sorafenib has become the standard first-line treatment for patients with advanced HCC and acts by inducing alterations in tumor vascularity. We wanted to evaluate the feasibility of dynamic CEUS (D-CEUS) as a predictor of early tumor response to sorafenib and to correlate functional parameters with clinical efficacy end points.
Lingua originaleEnglish
pagine (da-a)1014-1021
Numero di pagine8
RivistaJournal of Hepatology
Volume59
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • Dynamic contrast enhanced ultrasound
  • Hepatocellular carcinoma
  • Sorafenib
  • Tumour response

Fingerprint Entra nei temi di ricerca di 'Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound'. Insieme formano una fingerprint unica.

Cita questo